Cutia Therapeutics (HKG:2487)
Hong Kong · Delayed Price · Currency is HKD 5.15
+0.11 (2.18%)
Feb 13, 2026, 3:58 PM HKT
Cutia Therapeutics Market Cap
Cutia Therapeutics has a market cap or net worth of 1.87 billion as of February 13, 2026. Its market cap has increased by 47.58% in one year.
Market Cap
1.87B
Enterprise Value
1.44B
Revenue
274.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.15
Market Cap Chart
Since June 12, 2023, Cutia Therapeutics's market cap has decreased from 6.67B to 1.87B, a decrease of -71.96%. That is a compound annual growth rate of -37.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 1.87B | 13.44% |
| Dec 31, 2025 | 1.65B | -26.86% |
| Dec 31, 2024 | 2.26B | -32.43% |
| Dec 29, 2023 | 3.34B | -49.98% |
| Jun 12, 2023 | 6.67B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SinoMab BioScience | 2.48B |
| Antengene Corporation | 2.36B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 2.32B |
| Frontage Holdings | 2.19B |
| Mabpharm | 2.10B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.98B |
| Zhaoke Ophthalmology | 1.90B |
| Immunotech Biopharm | 1.60B |